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Generate C. glabrata HMR knockout strain:
cg_HAT1 -catalytic subunit of HAT-B histone acetyltransferase.
cg_AHC1 -structural subunit of ADA histone acetyltransferase.
cg_SPP1 -subunit of COMPASS histone methyltransferase. 
2.
Analyse mutant strain phenotypes:
-Azole/echinocandin resistance.
-In vivo virulence.
-Oxidative/osmotic stress tolerance.
-Biofilm formation.
3.
Gene expression analysis:
RTPCR, RNA-seq (WT and mutants +/-fluconazole)
Target histone-modification pathways pharmacologically?
4.
Comparative epigenomics:
Western blot, ChIP, ChIP-seq The deletion of cg_HAT1, cg_AHC1, or cg_SPP1 increases fluconazole resistance in C. glabrata and impacts sensitivity to various stressors.
HMR knockouts show increased biofilm formation and hypervirulence in an insect infection model.
The advancement of modern medicine has increased the survival of critically ill and immunocompromised patients. However, this advancement has also expanded the population at risk of an invasive fungal infection; fungal diseases now cause over 1.5 million deaths each year (1) . Candidiasis is one of the most prevalent mycoses in the world, and while over 30 Candida species have been implicated in infections, over 75% of cases are caused by C. albicans and C. glabrata (2) . C. glabrata displays some of the highest mortality rates and incidences of multidrug resistance among the Candida species, and intriguingly, C. glabrata also possesses a unique phylogeny among the Candida genus, sharing more sequence similarity with Saccharomyces cerevisiae than other Candida species (3) . As such, C. glabrata is theorised to have evolved pathogenicity independently of other Candida species, while retaining a considerable degree of genetic similarity with non-pathogenic yeast. This makes C. glabrata a valuable model to test our hypothesis that epigenetic phenomena (namely, histone modifications) can influence evolutionary pathways.
Comparative genomic approaches (4) were previously used to identify 19 histone modificationrelated (HMR) genes which are predicted to be under positive selection in C. glabrata, and thus contribute to the yeast's pathogenic phenotypes. To test these in silico predictions, a reverse-genetics approach is being employed, wherein each gene is individually knocked out, before phenotypic assays and gene expression analyses are used to determine whether the gene contributes to virulence. The output of this work links the regulation of histone modifications, and therefore potentially epigenetic processes, to evolution, and may be leveraged to identify novel pharmacological targets. In silico predictions that histone modification genes influence C. glabrata pathogenicity are supported experimentally, as strains with impaired histone acetylation/methylation show altered virulence phenotypes. Furthermore, preliminary data suggests that clinical isolates with altered virulence phenotypes contain nonsynonymous substitutions within histone modification genes.
2. RNA-seq evidence details the response of both WT and mutant strains to fluconazole, and implies that C. glabrata acetyltransferase mutants may be transcriptionally poised to tolerate azole treatment.
3.
The relationship between histone acetylation/deacetylation and virulence demands further study. ChIP/ChIP-seq experiments are underway to mechanistically link histone modifications with altered gene expression and pathogenicity.
4. Seven of the remaining 16 genes under positive selection are also involved in acetylation/ deacetylation pathways. These will be the next subjects of the workflow. Ultimately we hope to assess a range of epigenetic processes as potential evolutionary drivers, and pharmacological targets.
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